Search

UPTRAVI 1400 µG, Comprimé pélliculé

Details

--- Description
Pack Boite de 60
Strength (Dosage) 1400 µG
Laboratory MAPHAR
Ingredients Sélexipag
Therapeutic class Antihypertenseur pulmonaire, agoniste sélectif du récepteur IP
ATC code B01AC27
PPH $2,900.10
PPV $2,957.30
Refundable No
Refund base $0.00
Refund rate $0.00
Table A
Marketing status Commercialized
Type Not specified
Uses Traitement de l'hypertension artérielle pulmonaire (HTAP) chez les patients atteints d'une limitation fonctionnelle avancée (classe fonctionnelle III/IV de la NYHA) pour retarder la progression de la maladie.
Warnings
Dosage
Avoid
Side effects
Interactions

Medications with one or more of the ingredients above


Medications under one or more of the therapeutic classes above


Medications from the same laboratory


Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.